Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Histamine dihydrochloride plus IL-2 as maintenance in AML
CTR20132572Phase 2Active
- Sponsor
- Jilin Yixin Pharmaceutical
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of histamine dihydrochloride in acute myeloid leukemia (AML), sponsored by Jilin Yixin Pharmaceutical. Started Apr 2014; status: active.
02
Drugs
histamine dihydrochloride
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on CTR20132572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132572.